Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Alessandro Assandri"'
Autor:
Marco Sardina, Chiara Leuratti, Alessandro Assandri, Paolo Ventura, Markus Müller, Martin Brunner
Publikováno v:
Pharmacology. 92:207-216
Background/Aims: Absorption, biotransformation and elimination of safinamide, an enantiomeric α-aminoamide derivative developed as an add-on therapy for Parkinson's disease patients, were studied in healthy volunteers administered a single oral dose
Autor:
Alessandro Assandri, Peter Anderer, Gerda M. Saletu-Zyhlarz, Dorothea Nosiska, Bernd Saletu, Michael Wolzt, Emanuele Noseda, Fabrizio Nannipieri
Publikováno v:
Neuropsychobiology. 59:110-122
Effects of ABIO-08/01, a new potentially anxiolytic isoxazoline, on regional electrical brain generators were investigated by 3-dimensional EEG tomography. In a double- blind, placebo-controlled, multiple-ascending-dose study, 16 healthy males (30.2
Autor:
Sergio Rosini, Alessandro Assandri, Peter Anderer, Paola Nessi, Gerda M. Saletu-Zyhlarz, Bernd Saletu, Heribert V. Semlitsch, Michael Wolzt, Fabrizio Nannipieri
Publikováno v:
Neuropsychobiology. 59:100-109
In a double-blind, placebo-controlled, multiple-ascending-dose study, the encephalotropic and psychotropic properties of ABIO-08/01, a new potentially anxiolytic and nootropic isoxazoline, were studied in 16 young healthy males. In a randomized nonba
Autor:
Svetlana Culic, Alessandro Assandri, Fabrizio Nannipieri, Peter Anderer, Bernd Saletu, Gerda M. Saletu-Zyhlarz, Michael Wolzt, Sergio Rosini
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 23:243-254
Early pharmacological studies in animals demonstrated that ABIO-08/01, a new isoxazoline, exerted anxiolytic and anticonvulsant, but also cognition-enhancing properties. Thus, the aim of the present double-blind, placebo-controlled multiple-ascending
Autor:
Bernd Saletu, Alessandro Assandri, Gerda M. Saletu-Zyhlarz, C. di Padova, M. Corrado, O. Arnold, Peter Anderer
Publikováno v:
European Neuropsychopharmacology. 15:533-543
In a double-blind, placebo-controlled crossover study, the effects of S-adenosyl-l-methionine (SAMe) on brain function measures of 12 normal elderly volunteers (6 m/6 f, aged 57-73 years, mean: 61 years) were investigated by means of EEG mapping and
Autor:
Leopold Linzmayer, Alessandro Assandri, Peter Anderer, Gerda M. Saletu-Zyhlarz, C. di Padova, Bernd Saletu, Heribert V. Semlitsch, Elisabeth Lindeck-Pozza
Publikováno v:
Journal of Neural Transmission. 109:1505-1526
In a double-blind, placebo-controlled cross-over study, the acute and subacute effects of S-adenosyl-L-methionine (SAMe), or ademetionine, on brain function and behavior of 10 elderly normal healthy volunteers (5 males and 5 females, aged 56-71 years
Autor:
C. DiPadova, Alessandro Assandri, Gerda M. Saletu-Zyhlarz, Wolfgang Prause, Bernd Saletu, Elisabeth Lindeck-Pozza, Heribert V. Semlitsch, Peter Anderer
Publikováno v:
International Congress Series. 1232:237-241
The effects of S -adenosyl- l -methionine (SAMe)—a naturally occurring molecule with antidepressant properties—on event-related potentials (ERPs) were investigated in normal healthy volunteers (10 young subjects aged 22–33 years and 10 elderly
Publikováno v:
Journal of High Resolution Chromatography. 19:383-391
Twelve compounds, commonly used as industrial solvents and belonging to the chemical class of glycol ethers and glycol ether acetates, were investigated. Several analytical conditions, applied to single or connected capillary columns of different len
Publikováno v:
Journal of Chromatography A. 585:111-115
A selective reaction of ethyl carbamate (urethane) and methyl urethane (urethylane), as internal standard, with xanthydrol was effected to detect urethane after extraction from Italian aqua vitae (grappa) samples. The xanthylamides formed were determ
Autor:
Gerda M, Saletu-Zyhlarz, Peter, Anderer, Michael, Wolzt, Heribert V, Semlitsch, Alessandro, Assandri, Paola, Nessi, Fabrizio, Nannipieri, Sergio, Rosini, Bernd, Saletu
Publikováno v:
Neuropsychobiology. 59(2)
In a double-blind, placebo-controlled, multiple-ascending-dose study, the encephalotropic and psychotropic properties of ABIO-08/01, a new potentially anxiolytic and nootropic isoxazoline, were studied in 16 young healthy males. In a randomized nonba